08:00 , Dec 10, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: V-set and immunoglobulin domain containing 4 (VSIG4); CD59; complement C5b-9 membrane attack complex (MAC)

Inflammation INDICATION: Shock / trauma In vitro and mouse studies suggest a VSIG4-CD59 fusion protein could help treat traumatic brain injury (TBI). In vitro, dimers of the VSIG4-CD59 fusion protein bound complement 3b (C3b) with a Kd...
07:00 , Jul 28, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Melanoma Acid phosphatase 5 tartrate resistant (ACP5); fascin homolog 1 actin-bundling protein (FSCN1); homeobox A1 (HOXA1); heat shock...